L. Garegnani,J. V. A. Franco,A. Ciapponi,V. Garrote,V. Vietto and S. A. P. Medina. Ventriculo-peritoneal shunting devices for hydrocephalus. Cochrane Database of Systematic Reviews. 2020(6):10.1002/14651858.CD012726.pub2.
Ventriculo-peritoneal shunting devices for hydrocephalus Ver más »
V. Alfie,A. O. Alcaraz,S. G. Marti,D. A. Pichon-Riviere and F. Augustovski. VALUE FRAMEWORK FOR ASSESSMENT OF DIAGNOSTIC TECHNOLOGIES: A LATIN AMERICAN CASE. Value in Health. 2020;23.
VALUE FRAMEWORK FOR ASSESSMENT OF DIAGNOSTIC TECHNOLOGIES: A LATIN AMERICAN CASE Ver más »
P. Carrete,F. Augustovski,N. Gimpel,S. Fernandez,R. Di Paolo,I. Schaffer and F. Rubinstein. Validation of a telephone-administered geriatric depression scale in a hispanic elderly population. J Gen Intern Med. 2001;16(7):10.1046/j.1525-1497.2001.016007446.x.
I. D. Gallos,A. Papadopoulou,R. Man,N. Athanasopoulos,A. Tobias,M. J. Price,M. J. Williams,V. Diaz,J. Pasquale,M. Chamillard,M. Widmer,Ö. Tunçalp,G. J. Hofmeyr,F. Althabe,A. M. Gülmezoglu,J. P. Vogel,O. T. Oladapo and A. Coomarasamy. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018;12(12):10.1002/14651858.CD011689.pub3.
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis Ver más »
W. R. Parry Smith,A. Papadopoulou,E. Thomas,A. Tobias,M. J. Price,S. Meher,Z. Alfirevic,A. D. Weeks,G. J. Hofmeyr,A. M. Gülmezoglu,M. Widmer,O. T. Oladapo,J. P. Vogel,F. Althabe,A. Coomarasamy and I. D. Gallos. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2020;11(11):10.1002/14651858.CD012754.pub2.
L. Rey-Ares,A. Hernandez-Vasquez,V. Irazola,D. Comande and F. Augustovski. USES AND APPLICATIONS OF EQ-5D IN LATIN AMERICA & THE CARIBBEAN: SYSTEMATIC REVIEW AND BIBLIOMETRIC ANALYSIS. Value in Health. 2017;20(9):10.1016/j.jval.2017.08.2801.
F. Cicora,V. Escurra,S. Silguero,I. M. González and J. E. Roberti. Use of kidneys from trypanosoma cruzi-infected donors in naive transplant recipients without prophylactic therapy: the experience in a high-risk area. Transplantation. 2014;97(1):10.1097/01.Tp.0000437673.86339.82.
F. Cicora,M. Paz,F. Mos and J. Roberti. Use of bortezomib to treat anti-HLA antibodies in renal transplant patients: a single-center experience. Transpl Immunol. 2013;29(1-4):10.1016/j.trim.2013.08.003.
F. Cicora,M. Paz,F. Mos and J. Roberti. Use of belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathy. Case Rep Med. 2013;2013:10.1155/2013/260254.
M. Berrueta,J. Hemingway-Foday,V. R. Thorsten,R. L. Goldenberg,W. A. Carlo,A. Garces,A. Patel,S. Saleem,O. Pasha,E. Chomba,P. L. Hibberd,N. F. Krebs,S. Goudar,R. J. Derman,F. Esamai,E. A. Liechty,J. L. Moore,E. M. McClure,M. Koso-Thomas,P. M. Buekens,J. M. Belizán and F. Althabe. Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries. Reprod Health. 2016;13(1):10.1186/s12978-016-0176-2.2016
